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 i 
Abstract 
 
The mean glandular dose (MGD) was measured for a breast phantom by using 
molybdenum/molybdenum and molybdenum/rhodium target/filter combinations, at 
different kVp 26, 28 and 32 kilovolts. The phantom thickness was 7.5cm and was 
made of BR12 material. The change of dose was studied as a function of depth inside 
the phantom at different depths from the surface, namely 3.3, 4.3 and 5.3cm, by using 
TLDs. It was found that the MGD value for different combinations of beam quality 
(HVL) and energy (kVp) did not exceed the recommended values given by different 
protocols. 
The Mo/Rh target/filter required lower doses to achieve the same or better results 
compared with the Mo/Mo target/filter. The change in the surface dose as a function 
of kVp was more significant for Mo/Rh than for the Mo/Mo. 
Studying the change in dose within the breast, as a function of depth gives a better 
understanding of the interactions between radiation and tissue inside the breast. It 
should be noted that the MGD is a tool for optimization of the mammography 
parameters. However, the MGD should not be used directly to estimate the risk of 
determinable health effects from mammography. This will ultimately help to 
determine limits for the breast surface dose and a better understanding of cancer risk. 
In future work, we will try to measure the change of the dose as a function of depth by 
using more kVp, HVL, different breast composition and different target/filter 
combinations to give a wider picture for different situations. 
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1 Introduction 
 
Cancer refers to a group of diseases in which cells in a part of the human body 
grow abnormally. The common factor for different types of cancers is that they all 
start when cells grow out of control. Untreated cancer can lead to death because breast 
cancer is a malignant tumor, which usually starts from the mammary glands in the 
breast [1].  
 
Breast cancer is the most common cancer among women all over the world [1-4]. 
According to the American Cancer Society, the chances of an American female 
developing breast cancer in her life time, are about 12% [2]. The New Zealand Breast 
Foundation shows that the average risk of a New Zealand woman to be diagnosed 
with breast cancer in her life time is 11% [1, 3, 5].  
In general, most breast cancer societies confirm that breast cancer is the second 
leading cause of death of all cancer types for women [1-3, 5]. 
 
Researches agree that early detection of breast cancer can save many lives every year 
[1-2]. However, as for other cancer types, breast cancer is detected after symptoms 
appear in the later stages because, in most cases, there are no symptoms of the disease 
during the early stages. To detect the disease, a screening test such as a mammogram 
is recommended to find the cancer before the symptoms appear [1-2, 5].  
 
Mammography refers to the x-ray examination designed specially for detecting 
human breast pathology [6]. Breast screening relies on mammography to detect 
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cancer in its early stages due to small changes in tissue composition. As with any 
examination that includes x-rays, there is always a small stochastic risk of inducing 
cancer. It is therefore important to evaluate the risk from the dose delivered to the 
patient during the screening process [7]. In other words, to keep the dose as low as 
reasonably achievable (ALARA) [6, 8-9]. 
   
Accurate dosimetry of the dose delivered to the breast during the screening process 
has been of interest to a number of investigators [10-11]. The dose delivered to the 
breast can be estimated by measurements on patients or in most cases by using a 
phantom. The dose delivered to the breast depends on: the x-ray spectrum 
(target/filter) combination; breast composition (a ratio of glandular tissue to fat 
tissue); breast thickness and the kVp value [7, 12-15].  
Because of the low energies used in mammography, typically in the range between 
25-35 kVp during screening, the dose within the breast will decrease rapidly as the 
depth increases. This requires using a quantity to represent the risk from using x-rays 
on the breast. In other words, this quantity needs to represent the dose delivered to the 
whole organ (breast) [16-17]. 
 
Mammary glands are considered to be the most radiosensitive part of the breast [17-
19]. Therefore, measuring the mean glandular dose (MGD) within the breast is the 
recommended quantity to evaluate the risk from radiation to the breast. MGD is a 
quantity that represents the average dose delivered to the breast. It cannot be 
measured directly because it depends on the kVp of the x-ray tube; target/filter 
combination; breast composition and breast thickness [7, 13, 18]. 
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The quantities required to find the MGD is the normalized glandular dose (DgN). This 
represents the dose delivered, per unit of entrance surface exposure (XESE), for a given 
beam quality (HVL); breast composition; breast thickness and kVp [4, 6, 10-12]. It 
also needs to be taken into consideration that the DgN values vary depending on the 
target/filter combination used in mammography unit [13, 15, 19-21]. The DgN values 
are available in standard tables depending on all the above factors 20-21]. 
 
Investigators also study the relationship between the surface dose and the dose, as a 
function of depth, within the breast as one of the methods to determine the risk of 
mammography [16]. The entrance surface dose can be determined by measuring the 
x-ray output with an ionization chamber. To estimate the dose inside the phantom 
(breast) at different depths, dosimeters, such as thermolminescent dosimeter (TLD), 
need to be used [16-17].  
 
In this research the phantom that will be used to estimate the dose delivered to the 
breast is a phantom made from BR12 material [15-16, 21]. This phantom has the 
standard breast composition (50% glandular tissue/50% fat tissue) and 7.5cm 
thickness. Different target/filter combinations will be used: 
molybdenum/molybdenum (Mo/Mo) and molybdenum/rhodium (Mo/Rh) and 
different kVp: 26, 28 and 32 kilovolts will be applied for both target/filter 
combinations. 
This research also includes finding the change in dose, inside the phantom (breast), as 
a function of depth, by placing the TLDs inside the phantom at different depths: 3.3, 
4.3 and 5.3cm which were chosen because of the set up of the phantom slabs. 
Measuring the change of the dose, as a function of depth within the breast, gives a 
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better understanding of the change in dose inside the breast, depending on the kVp, 
target/filter combination and beam quality [16]. In addition, measuring the surface 
dose and the change of dose with the depths helps to determine limits for the breast 
surface dose and a better understanding of cancer risk. 
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2 Background  
 
In this chapter some basic background information is provided. First I will briefly 
describe the breast anatomical structure with a few little more details about the 
mammary glands. This will be followed by discussing the structure of the 
mammography unit with more details about the x-ray tube and the compression 
paddle. Finally this chapter will discuss the in vivo dosimetry for the breast. 
2.1 Breast Anatomy 
In order to know the changes that can happen to the breast under abnormal 
situations, it is important to know the anatomical structure and constituency of the 
breast [23].  
In general, a mature female’s breast is composed of glands and fat. The human breasts 
do not contain bone or muscles [18, 23]. Each breast has a nipple where the ducts of 
the mammary glands open onto the body Figure 2.1. The most important anatomical 
part of the breast is the mammary glands, which are common in both sexes [23]. 
However, for males these glands remain rudimentary and functionless [7].  
 
Figure  2.1: Breast normal anatomy cross-section view [24] 
Fat 
Mammary 
Glands 
Nipple 
Ducts 
Ribs 
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The main function of the female breast is to produce milk for the newborn. The 
mammary glands produce the milk from water and nutrients taken from the 
bloodstream [23]. Figure 2.1 shows the ducts, which work as contact channels 
between the mammary glands and the nipple. Internally, the breast structure is the 
same for all females, only the size and shape of the breast varies [23-24]. 
 
The size and shape of the breast may change over time due to, for example, the 
menstrual cycle, pregnancy and age [23-24]. Some women have more mammary 
glands in their breast than others: this is mostly correlated with age where younger 
women have more mammary glands than older women. Some women have more fatty 
tissue or more connective tissue, which makes the breast more firm [7, 23-24].  
 
The main subject of this research, from a medical physics point of view, is the 
mammary glands as they are the most sensitive part of the breast and are vulnerable to 
cancer. These glands are also highly responsive to hormonal changes [23]. According 
to Frederic H. Martini, “mammary glands of the breast are anatomically related to 
apocrine sweet glands. A complex interaction between sex hormones and pituitary 
hormones controls their development and secretion.” [23] 
 
The anatomical structure of the breast is mostly fat, unlike other parts of the body. 
Studies of the breast require images with maximum visualization of the breasts’ 
anatomy to detect a non-palpable cancer [18, 23].  When using ionizing radiation for 
such an organ containing sensitive glands, it must be optimized to avoid increasing 
the chances of inducing cancer in the patient [18, 25].  X-ray mammography is one of 
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the most effective techniques used to detect, diagnose and show a variety of breast 
diseases. Mammography is designed to detect breast pathology [7, 18, 25]. 
 
2.2 Mammography 
Mammography is studying and imaging the breast, using images created with x-ray 
radiation [6-7, 18]. The x-rays used for mammography show the fibrous, fatty and 
glandular tissues of the breast. The actual test is known as a mammogram. There are 
two types of mammograms [18]. Firstly, a screening mammogram which is used for 
women with no symptoms of breast cancer, to detect any cancer in its early stage. A 
screening mammogram, can be done from two different angles: oblique (from the side 
of the breast), and a craniocaudal (from above the breast) [18, 26]. Secondly, a 
diagnostic mammogram the purpose of which is to evaluate an existing problem, such 
as a discharge from the nipple or a lump [26].  
 
X-ray mammography is a radiographic examination designed to detect breast 
pathology. The objective of a radiographic examination is to produce an image with 
maximum visualization of the breast’s anatomy for both normal and abnormal tissues 
(signs of disease) [18, 26]. Mammography is considered the best radiographic 
examination to meet this objective. This is because mammography uses a low energy 
radiation dose as the attenuation differences between a normal tissue and a cancerous 
tissue increases rapidly with the lowest x-ray energies [6, 26, 27].  
 
Mammography uses low kVp with either a molybdenum (Mo), Rhodium (Rh) or 
Tungsten (W) target in the x-ray tube coupled with specialized beam filtration. Figure 
2.2 shows the design of a mammography machine [18].  
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     (a)                                                                                                  (b) 
Figure  2.2: Mammography Machine. (a)  a picture of a real mammography machine [28] (b) same machine 
from inside showing the x-ray tube, filter, collimator and compression paddle [18]. 
A mammography machine has two major components that make it more effective and 
sufficient for breast screening than any other radiographic machines. These two 
components are, the types of x-ray tube i.e. target/filter combination and the 
compression paddle. 
 
In mammography, the doses to the patients are small and do not reach the threshold 
for determining risk effects. The probability of the occurrence of stochastic effects is 
also small. However, the probability of stochastic effects occurring increases as the 
absorbed dose increases [27, 29]. To achieve the optimal x-ray energy with 
mammography requires the use of a specific x-ray target material to generate a 
characteristic x-ray of the desired energy and the use of a filter to attenuate and 
remove the undesirable low and high x-ray energy, caused by the Bremsstrahlung 
spectrum [18, 30-31]. Doses to the patient can change depending on the choice of the 
x-ray tube used (target/filter) and the breast characteristics (thickness, density, etc). 
 
 
 
 
X-ray tube 
Filter  
Compression  
Paddle 
Breast 
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2.2.1 X-ray tube 
The most common material used for the anode in the mammography x-ray tube is 
molybdenum (Mo) with (Z=42), although one can find rhodium (Rh) with (Z=45) and 
tungsten (W) with (Z=74) in some machines [18]. The characteristic x-ray production 
of molybdenum and rhodium is the reason for choosing these two materials as the 
anode material. These materials are more commonly used world-wide in 
mammography machines rather than tungsten [7, 18].  
 
Using molybdenum and rhodium within the x-ray tube has the great advantage of 
achieving the required radiographic contrast with the soft breast tissues because of 
their lower atomic number compared with that of tungsten. They produce major 
characteristic x-ray peaks at 17.5 and 19.6 keV for Mo, and 20.2 and 22.7 keV for Rh. 
Figure 2.3, shows the process of producing Bremsstrahlung and characteristic 
radiation for a molybdenum target [16, 18].  
 
 
Figure  2.3: The output of the (Mo) x-ray system is composed of bremsstrahlung and charateristic radiation 
[18] 
 10 
 
One of the common filter materials used in mammography is the molybdenum filter 
with a (30µm) thickness, which can be used in combination with a molybdenum 
target (Mo/Mo). The rhodium filter is another one with a (25µm) thickness and can be 
used in combination with the molybdenum target (Mo/Rh). Also, the rhodium filter 
can be used with the rhodium target (Rh/Rh) [18, 33-34]. The reason for having the 
filter with the x-ray tube is to reduce the low energy x-rays and the high energy X-
rays so they are not incident upon the patient [18] as Figure 2.4 shows. 
 
Figure  2.4: (a) Unfiltered spectra from a Mo target contains a relatively large fraction of low- and high 
energy, (b) filter spectra from a Mo target where the filter terminates the majority of the low- high energy 
[18] 
2.2.2 Breast Compression 
The compression of the breast during a mammogram is a very important part of 
the examination process because it helps improve the quality of the mammogram [18, 
34-36]. The compression of the breast is facilitated by using the compression paddle 
where the breast is placed between two parallel flat plates. One of these two plates is 
moveable to produce a force over the breast. The main idea of this compression is to 
reduce the breast thickness and this will give the x-ray the chance to penetrate the 
breast more uniformly [34], as shown in Figure 2.5.  
The benefits of breast compression during screening or diagnosis are [18, 34]:  
• Immobilizes the breast to eliminate blurring of the image caused by motion.  
Mo target Filter 
 
Mo target 
Unfilter 
 
 
Energy, keV 
 
(a) 
 
(b) 
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• Reduces x-ray scatter and increases the contrast. 
• Increases the sharpness of the picture and reduces the geometric blurring. 
• Allows the use of a lower x-ray dose since a thinner amount of breast tissue is 
being imaged 
 
 
Figure  2.5: Standard mammography views are taken first [37]. 
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2.3 Breast Dosimetry  
Detecting cancer in the mammary glands in its early stages increases the chances 
of recovery [7, 18]. However, the mammography, compared to other conventional x-
ray machines, has the advantage of using target materials with low atomic numbers 
and because the operated energy range for mammography units is 25-35 kVp, the 
image quality and the energy of the x-ray used, needs to be taken into consideration 
[18]. In other words the main goal is to have high image quality to maximize the 
detection of abnormalities and to give a low dose to minimize cancer induction [26, 
27]. 
 
As with any technique based on ionizing radiation, there is a small but a real 
significant risk of radiation to induce a tumor [7]. Thus the mammography machine, 
while having the potential to detect cancer, can also increase the cancer incidence in 
the radiosensitive tissue during the examination [38]. According to (ICRP, 2007) the 
breast has 0.12 tissue weighting factor for the effective dose examination [39].   
Therefore, it is necessary to evaluate (optimize) the dose delivered to the breast or to 
any other organ in the body to minimize the risk of radiation induced cancer [7, 26]. 
Optimization will increase the benefit/risk ratio for the diagnostic procedure [7]. The 
benefit term from this ratio, presents the improvements on the diagnosis procedure, 
whereas the risk expresses the hazard from exposing the patient to an ionizing 
radiation, which always needs to be minimized [7, 26-27].   
 
Using the term in vivo in the diagnostic process refers to measurements of the dose 
delivered to the patient during the treatment or the diagnostic examination [7, 40-41]. 
This measurement can be taken by placing the measurement instruments on the skin 
 13 
or inside the patient very close to the target [7, 40]. In the absence of the patient these 
instruments are placed on a phantom. In vivo dosimetry gives a better understanding 
of the benefit/risk ratio and checks the behavior of the medical device 
(mammography) [40-41]. Knowledge of the actual dose delivered to the breast 
depends on: the characteristics of the equipment (x-ray tube target/filter, beam 
quality) and on the size of the breast/phantom composition [16, 40].  
 
Finding the mean absorbed dose to mammary glands is the preferred measure to 
express the radiation risk of mammography [7, 16, 42]. Before choosing mammary 
glands there were different trials to measure the breast dose. For example Boag et al, 
1976 considered using the total energy imparted on the breast [7]. The relative risk 
was determined from the measurements of depth dose curves or entrance and exit 
doses [7]. The National Cancer Institute NCI, (1977) [43] suggested using the mid-
breast dose to measure the radiation risk to the breast. But none of these trials gave 
enough details about the breast dose [7].  
In 1976, Karlsoon in his article, "Absorbed Dose in Mammary Radiography” 
suggested that finding the mean dose of the mammary glands would be more useful as 
a measurement of the risk [7]. His suggestion was based on the anatomical structure 
of the breast and the energy absorbed by it, as the mammary glands are the part of the 
breast most sensitive to radiation. A few years later, the International Commission on 
Radiological Protection (ICRP, 1987), and other protocols (European protocol, the 
British Institute of Physical Sciences in Medicine (IPSM 1989, 1994)  [7, 14] 
supported Karlsoon’s suggestion and recommended using the mean glandular dose 
(MGD) as the most appropriate quantity to represent the radiation risk to the breast [7, 
17]. 
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Accurate assessment of the surface exposure levels is considered a first step [16]. 
Additionally, the relationship between the surface exposure and the absorbed dose to 
tissue, as a function of depth, is also important [16-17, 44]. The breast surface 
exposure is typically translated into a mean glandular dose (MGD) to access the 
radiation risk within the mammary glands [7, 10, 12-13]. Thus, the mean glandular 
dose (MGD) can be defined as the quantity used to express the absorbed dose by the 
breast to estimate the radiation risk [7, 10]. However, even with the agreement of 
using MGD as a measurement of the radiation risk to the breast, measuring the MGD 
directly, is currently not measurable because these glands are located inside the breast 
[7, 10, 16]. However, the MGD can be determined indirectly by two methods [7]: 
 
1. A breast phantom  
2. Direct surface measurements on the patient 
In this research, a breast phantom was used to determine the MGD. 
 
2.4 Overview of approach 
This chapter discussed some points briefly, and others in more detail: female 
breast structure and the effect of the mammography radiation on the breast. The 
mammography unit structure and why it is considered the best unit, using ionizing 
radiation to detect breast cancer at the early stages. In the next chapter, materials used 
in this research will be characterized and the method followed for doing the 
measurements.  
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3 Materials and Methods 
 
In this chapter we will discuss the equipment used in this research: the 
mammography unit, thermoluminescence dosimeters (TLD), phantom and the 
ionization chamber. Also, the second part of this chapter will show the experimental 
method (preparation process) for the TLD and the phantom. 
3.1 Mammography Unit 
All the experiments described in this research were performed using the 
Siemens Nova 3000 mammography unit [45], shown in Figure 3.1. Either a 
molybdenum/molybdenum (Mo/Mo) or a molybdenum/rhodium (Mo/Rh) anode/filter 
combination was used. The voltage range of the x-ray tube mammography unit is 
from 23-35 kVp, and the maximum field size is (18 X 24) cm2. 
 
Figure  3.1: MAMMOMAT 3000 Nova [45] 
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3.1.1 Thermoluminescence Dosimeter  
The use of thermoluminescence dosimeters (TLDs) has been accepted in all 
areas of the radiographic imaging (x-ray) as one of two dosimeters types: (a) 
integrating dosimeters such as TLD optical dosimeters, and (b) electrical conductivity 
dosimeters such as semiconductor dosimeters [46-47]. 
 
A TLD is a phosphor on a solid crystal structure such as lithium fluoride (LiF), 
lithium borate (Li2B4O7) or calcium fluoride (CaF2). The most commonly used TLD 
is lithium fluoride (LiF) because of its high stability and its response to a wide range 
of energies used with mammography [47-48]. Also, lithium fluoride has the 
advantage of being very close to tissue equivalent due to its atomic number (Zeff ≈8) 
compared to 7.5 for tissue [46-48].  
 
After being irradiated, heating these crystalline materials is followed by the emission 
of visible light proportional to the amount of the radiation they are exposed to 
(absorbed dose). This emission of light with the application of heat is known as 
thermoluminescence. Measuring this amount of emitted light estimates the radiation 
dose delivered to these crystals. This technique is called the Thermoluminescence 
Dosimeter (TLD) [47-48].  
When TLD materials are exposed to ionizing radiation, electrons are raised to higher 
energy levels in the atoms of the TLD. Most of these electrons will return to their 
original state. Some of them become trapped in the higher energy levels.  Upon 
heating, they return to the ground state together with the emission of light. This light 
is what is usually measured as an expression of the amount of the radiation absorbed. 
However, some of these electrons will stay (trapped) in the higher energy levels [47]. 
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Experimentally, after irradiating LiF crystals, they are inserted into a heater “TLD-
reader” where a photomultiplier tube (PMT) converts the emitted light from the TLDs 
into an electrical signal that can be measured. Drawing the light emitted as a function 
of time, produces a so-called “glow curve” [46-48].  
The glow curve shows peaks, where each one of these peaks represents a different 
trapped energy level, and the area under the glow curve is used to measure the 
delivered dose [47-48, 50-51] as shown in Figure 3.2.   
  
Figure  3.2: Time-temperature profile and glow curve for LiF: Mg, Ti (TLD-100) [49] 
Thermoluminescence dosimeters come in many different shapes (powder, chips and 
rods) and in different sizes. There are many advantages of using TLDs for measuring 
dose, especially with mammography. Some of these advantages are [47-48, 50-51]: 
• Its small size makes it easy to use in many positions within the human body or 
in phantoms 
• TLD (LiF) can be used to measure a wide range of dose 10-5 – 103Gy 
TLDs are used for measuring the absorbed dose. The importance of measuring the 
absorbed dose from a diagnostic point of view, comes from [7]: 
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• Reducing the patient dose by improving the equipment design. 
• Improving the radiographic techniques as part of reducing the patient dose. 
 
However, there are some disadvantages of TLDs: one is the lack of uniformity 
(different TLDs have different sensitivities and this requires a group calibration or an 
individual calibration). Due to this lack of uniformity, TLDs must be calibrated before 
being used especially this study will be using two different target/filter combinations 
and may case small difference with dose measurements. Ionization chambers are 
mostly used to calibrate TLDs [46-48]. 
The ionization chamber will be placed at the same effective point of the 
measurements and exposed to the same dose the TLDs are exposed to. This makes the 
energy responses not an issue because they were calibrated at the same energies 
where the measurements were taken [16, 40, 46]. 
 
The disadvantage of the TLD is the time it needs in the annealing process (preparing 
for use). It is a compulsory step with TLDs before use. Annealing is resetting the 
TLDs by heating them to a high temperature reaching 400oC, in which all the 
dosimeters are placed in a TLD oven and exposed to heat for 2 hours followed by 
another 2 hours at (100oC) to release trapped electrons on the TLDs. This process can 
take up to 5 hours [46]. 
 
The type of TLD used in this research was a Harshow (TLD-100) with a lithium 
fluoride base with Mg:Ti doped (LiF: Mg:Ti). The TLDs were 3.1 × 3.1 × 0.9 mm3 
and were chip-shaped. They were all used to measure the dose in different depths 
inside a phantom, as described in the next section. 
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3.1.2 The Phantom  
A phantom is a tissue equivalent material corresponding to the organ of interest 
(breast in this study). It reflects the following characteristics: linear and mass 
attenuation coefficient, mass absorption coefficient, energy distribution, size and 
shape. The advantages of the phantom measurements are [7, 53]: 
• Results are more reproducible 
• No interference with patient examinations 
 
There are a few requirements the phantom must have, to be considered as a suitable 
phantom to simulate the breast [7, 53-54]:  
• Composition of the breast (percentage of the glandular tissue to fat tissue)  
• Sensitive to small variations (temperature and pressure) 
• Easy to use 
• Solid and large enough to provide appropriate scatter conditions  
• Ability to change thickness  
 
In general, phantom measurements give a better understanding of the dose level 
applied under different conditions and help to assess the effects of the machine 
performance, such as the dose output [7, 54-55]. Also, using the phantom helps 
comparison between different x-ray tubes depending on the size, shape, and 
composition of the breast (ratio of mammary glands to fat tissues) [7, 52, 54].  
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The phantom used for this study represents the female breast and is called tissue 
equivalent phototimer consistency testing slabs (Model 014A) by Fluke Biomedical 
Company, Virginia, United State of America [55]. It resembles a compressed situation 
and standard granularity with a tissue consisting of 50% fatty tissue and 47% 
glandular tissue [7, 16, 34-35, 40]. This phantom is made from a material known as 
BR-12 or BR50/50 [7, 16].  The phantom is shown in Figure 3.3. This phantom is 
designed to be in slabs (rectangular shaped) 12.5cm length, 10cm width, with 
different thicknesses of 2, 1, and 0.5cm [55]. This is to makes it easier to study the 
dose delivered to the breast as a function of depth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  3.3: Tissue equivalent phototimer consistency testing slabs (model014A) [55] 
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3.1.3 Ionization Chamber 
The ionization chamber is the best option to use in the calibration process for 
the TLDs [16, 40-41]. In this research the ionization chamber used was model 
96035B dual entrance window parallel plate with a flat response suitable for both 
diagnostic and mammography. It was made by Supertech Company, Elkhat, United 
States of America [56]. One of the entrance windows is used for Mammographic 
measurements see Figure 3.4. The dimensions of the ion chamber were 6.35±0.04cm 
diameter by 1.33±0.01cm thickness, where the wall is made of graphite-coated acrylic 
[56]. The ionization chamber was placed on the surface of the phantom to measure the 
entrance dose for different kVp from different x-ray target/filters, Mo/Mo and Mo/Rh 
with take inconsideration the compression paddle placed on top of the chamber to 
avoid all the backscatter. 
 
 
Figure  3.4: The model 96035B ion chamber [56] 
Direction of 
incident radiation 
 
Active region 
 
3.56cm 
2.86cm 
6.35cm 
1.30cm 
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3.2 Experimental Method 
3.2.1 Thermoluminescence Dosimeters (TLD)  
3.2.1.1 Preparation  
Before using TLDs they must be kept in a TLD keeper to avoid any damage 
(scratches, touching by hands). The TLD-keeper is a box that stores TLDs separately 
with a specific coordinate (row and column) as shown in Figure 3.5. The TLD keeper 
used in this research could hold up to 50 TLDs.  
 1 2 3 4 5 6 7 8 9 10 
A           
B           
C           
D           
E           
Figure  3.5: The TLD keeper with the coordinates 
Preparing the TLDs for use starts with the annealing process, which is a compulsory 
step for all TLDs that are going to be exposed to radiation [46-48]. After TLDs are 
exposed to a known dose of radiation they have to be calibrated to make sure that all 
the dosimeters will have an equal dose response and sensitivity [46-48]. The 
calibration of the TLDs is followed by a pre-read annealing. Finally an automatic 
TLD-reader is used to read the measurement detected [46-48].  
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It is recommended to keep the time short between the annealing process and 
irradiation of the TLDs to minimize the effect of background radiation [46]. 
3.2.1.2 Group Calibration 
Because this research studies the dose as a function of depth we must have 
many of the TLDs divided in groups to cover all depths. It is easier to do the 
calibration of the dosimeters as a group (batch). All the groups were classified 
depending on the energy used and the depth, but each group was exposed to the same 
field size.  
 
The calibration process resulted in a group of TLDs that had an equal dose response 
and sensitivity. The standard deviation of all readings was within ±3% [46]. 
 
3.2.1.3 Pre-read Annealing 
Pre-read annealing is the first step in the reading process (read out) for the 
TLDs, and it immediately follows the irradiation of the TLDs [46]. In this step the 
TLDs are carefully removed from the TLD-keeper and are placed on the TLD oven 
tray (capacity 50 TLDs). The TLDs then need to be placed in small cylindrical holes 
on the disk to avoid losing one of the dosimeters due to the fan in the convection oven 
[46]. 
This step requires a heating of 10 minutes at 100oC, where the pre-read annealing 
process will take nearly 40 minutes. 
 
After the pre-read process is finished, the TLDs need to be placed in the automatic 
TLD-reader in groups to get the TLDs read out depending on the target/filter x-ray 
tube used, energy used and the depth. 
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3.2.1.4 The Automatic TLD-Reader 
The TLD-reader used in this research was the Harshaw Model 5500 
Automatic TLD-Reader, Figure 3.6. Up to 50 TLDs can be placed in the reader where 
each chip is heated at a rate of 10oC/second, and is exposed to a hot gas stream [46, 
48]. The light emitted from the dosimeters is converted, by the low noise in a high 
gain photo multiplier tube (PMT), into a current that is integrated. This results in the 
glow curve to give a reading in nanocoulombs (nC) [46, 57]. Each one of the readings 
is recorded under the name or number of the TLD.  
 
Figure  3.6: Harshaw Model 5500 Automatic TLD-Reader. The left part is where the TLDs are placed and 
exposed to the gas; the monitor shows the glow curve [57] 
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3.2.2 Phantom 
The phantom used for this study is a compressed phantom with 50/50 
composition tissues (glandular/adipose) designed in slabs. The maximum possible 
thickness of the phantom is 8.5cm but for this study the maximum phantom thickness 
used was 7.5cm.   
 
The important phantom slab is the one slab that carries the TLDs when they are 
exposed to radiation. This slab is the thinnest slab of all (0.5cm). It contains 15 holes, 
each of a cylindrical shape. We took a 5cm distance from the chest-wall edge and 
arranged all the holes in a matrix (3×5) to cover breast surface area (nipple edge) with 
a 3mm depth and 0.42mm diameter, as shown in Figure 3.7. These slabs are designed 
with the holes being at an equal distance from each other, and also symmetrically 
arranged to compare the dose for side edges and the central part of the phantom. 
  
Figure  3.7: The 0.5cm thickness slab, with the mold holes to place the TLDs during the test 
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Because the TLD thickness was almost 1mm and the hole depth was 3mm, this 
resulted in a gap of air between the phantom slabs when they were placed on top of 
each other. This affects the TLD readings because of the increase in backscatter. To 
avoid or minimize the backscatter, some Perspex, of the same shape and diameter of 
the holes but with 2mm thickness, was placed on top of the TLDs to cover the gaps, 
as shown in Figure 3.8. The holes’ diameter and the Perspex thickness helped to 
immobilize the TLDs inside the holes.  
 
 
 
 
 
Figure  3.8: The (0.5cm) slab thickness (bottom), have the TLD on blue and the Perspex on purple, covered 
with another phantom slab (top). 
 
 
3.2.3 Measurements  
 
It is important to have a suitable phantom that matches the requirements to 
simulate the organ being studied. In this study, using the breast phantom, there are 
two ways to carry out dose measurements [7, 58]: 
1. Measure the entrance surface dose (ESD) alone  
2. Measure the entrance and the exit doses 
 
Measuring just the entrance surface dose (ESD) does not take into consideration the 
fact that the dose will decrease as the depth increases [19]. However, measuring the 
ESD and the exit dose has been proven to be more useful. It also includes more details 
about the variation of the dose and the relation of that to the density of the breast [16, 
19, 58]. The second method shows the importance of in vivo dosimetry for the patient 
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or the mean glandular dose (MGD) for the breast [7, 40]. Overall, in vivo dosimetry 
helps improve the accuracy and precision of the dose delivered to the target [40].   
However, because of the difficulties of determining the MGD directly due to the 
location of the mammary glands, there are some protocols such as those in the 
Institute of Physical Sciences in Medicine (IPSM) (1989, 1994) [7, 21-22, 59] that set 
out the process to estimate the MGD. The methods of these protocols are based on the 
fact that the assessment of the surface exposure levels is considered as a first step to 
determine the MGD [16]. The other point, considered important with finding the 
MGD, is finding the relationship between the surface exposure and the absorbed dose 
to tissue, as a function of depth [16].  
 
The MGD is calculated by measuring the entrance surface exposure, XESE, and 
multiplying the XESE with the normalized glandular dose (DgN) [7, 16, 21-22] equation 
1 [34-35]. The normalized glandular dose represents the average glandular dose per 
unit entrance surface exposure. It depends on the breast thickness, beam quality, and 
breast composition [21-22]. The unit of the normalized glandular dose is typically 
tabulated in (mrad/R) [21-22] which corresponds to (0.01mGy/R) in SI units. 
MGD = X ESE( ) × DgN( )
mGy[ ] = R[ ]× mrad / R[ ]………Eq.(1) 
Taking into consideration that measuring the XESE by using the ionization chamber 
will be by mGy, but keeping the equation units most of the literature used, we convert 
the ionization chamber reading into (R), where 1R=0.00873Gy. 
The beam quality is expressed in half value layers (HVL) which depend on the kVp 
and the x-ray tube target/filter combinations. The kVps used in this research were 26, 
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28, and 32 kilovolts. The reason for choosing just three voltage values was because of 
time constraints, i.e. availability of resources at the hospital. 
 
 Beam Quality 
The process followed to obtain the HVLs was as follows [34]: 
1. Setting the ionization chamber at a distance of 65cm from the radiation source 
(same distance between the phantom and the radiation source) 
2. Collimating the x-ray beam so that the ionization chamber will be fully 
exposed in terms to minimize the backscatter 
3. Placing pure (more than 99.9%) aluminum layers on top of the ionization 
chamber, starting from the lowest layer thickness (1mm) and measuring the 
dose  
4. Adding another aluminum layer on top of the first one and repeating this step 
until we obtained half of the first measurement (without any aluminum layer) 
5. Adding another layer to find the second HVL value  
6. Checking the accuracy, by repeating the measurements again without using 
any aluminum, to compare with the first measurements 
7. Repeating the steps (1- 6) for the different energies used for the two x-ray 
target/filter combinations 
The measurements were then applied to equation 2 [34] to find the HVL for each 
energy: 
 
[ ] [ ]
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where, 
Ko: Dose measured with no aluminum  
Ta: Thickness of aluminum immediately below (Ko/2) 
Tb: Thickness of aluminum immediately above (Ko/2) 
Ka: Dose measured using Ta  
Kb: Dose measured using Tb 
The point to consider is that the breast dose varies widely with breast composition and 
thickness as well as the choice of imaging equipment and radiographic technique. 
Therefore, there are many different protocols European protocol, the British Institute 
of Physical Sciences in Medicine and methods designed to facilitate and estimate the 
appropriate value of the breast dose [7, 14, 16]. Each of these methods uses different 
phantom materials, phantom thickness, x-ray energies (kVp), x-ray tubes and 
dosimeters, such as TLD and films. TLDs are the most common dosimeter in most of 
these protocols [8].   
 
Classified the TLD 
The next step was to organize the TLDs needed for the measurements, 
depending on the depths and the nominal energies from the x-ray tubes. 
 
Initially, the Oncology Department at Christchurch Hospital offered (300) TLDs. 
These were classified into six major groups depending on the energy (kVp). Each 
group had 50 TLDs. The 50 TLDs were then divided into 3 smaller groups to be 
calibrated at 3 different depths 3.3, 4.3 and 5.3cm.  The reason for choosing these 
depths was because the existing different protocols covered only specific depths. For 
example, the American College of Radiology (ACR) chose 4.2cm; in the United 
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Kingdom they used 4.5cm and in Australia they used a 5cm depth [8]. The maximum 
number of the TLDs for each depth is 15, Table 3.1.  
Group Name Depth (cm) Energy (kVp) 
X-ray Tube 
(target/filter) 
Total  
(TLDs) 
A 3.3, 4.3, 5.3 26 Mo/Mo 50 
B 3.3, 4.3, 5.3 28 Mo/Mo 50 
C 3.3, 4.3, 5.3 32 Mo/Mo 50 
D 3.3, 4.3, 5.3 26 Mo/Rh 50 
E 3.3, 4.3, 5.3 28 Mo/Rh 50 
F 3.3, 4.3, 5.3 32 Mo/Rh 50 
Table  3.1: Classified the TLDs into groups depending on the x-ray energy. 
To study the dose, as a function of depth, using different target/filter x-ray 
mammography tube at different energies. Table 3.1 shows the calibration process was 
divided into two groups. The first group was the Mo/Mo target/filter x-ray tube for all 
energies and depths. The second group was the Mo/Rh target/filter x-ray tube for all 
energies and depths. 
The standard deviation of all readings should be within ±3%. Therefore, all the TLDs 
with a standard deviation higher than 3% were rejected.  
After the calibration process was completed, each group had more than 8 TLDs within 
the required standard deviation although some groups had 15 TLDs within the 
standard deviation.  
 
Part of the preparation for measurement was to set up the mammography machine to 
find the lowest dose that could be detected by the TLDs. To do this the ionization 
chamber was placed at these depths, and exposed to the same beam. The reading from 
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the chamber reflects the dose needed to get a readable value from the TLDs at any 
depth.  
 
For example, if the chamber reading is 100µGy as the lowest dose that the TLD can 
detect then we should set up the exposure factor to deliver no less than 100µGy exit 
dose. The reading varies depending on the depth, due to the change of the attenuation 
through the phantom material.   
 
The initial plan of this research was to obtain measurements using lower energies. 
Trials were done for an energy of 24 kVp for a Mo/Mo target/filter x-ray tube. Then 
the dosimeters were placed at different depths. It was however, difficult to detect a 
signal at the depth of 5.3cm due to the high attenuation. Because of these initial 
results no trials were done on the Mo/Rh for the same energy, and were not 
considered in this research.   
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4 Results 
4.1 Calculate the MGD 
Calculating the MGD depends on different factors, a few of these factors were 
not changed in this research i.e. the phantom thickness and composition. Also, part of 
these factors is the beam quality, HVL, which depends on the kVp and the target/filter 
combination. Table 4.1 and Table 4.2 show the measured HVLs for Mo/Mo and 
Mo/Rh target/filter, respectively, as a function of the 3 energies used in this research: 
 
kVp 
Ko 
(mGy) 
Ta 
(mmAl) 
Tb 
(mmAl) 
Ka 
(mGy) 
Kb 
(mGy) 
HVL 
(mmAl) 
26 6.88 0.3 0.2 3.39 4.16 0.29 
28 8.65 0.4 0.3 3.7 4.43 0.31 
32 12.58 0.4 0.3 5.79 6.83 0.35 
 4.1 : The HVL of 26, 28, 32 kVp for Mo/Mo target/filter mammography x-ray tube 
 
kVp 
Ko 
(mGy) 
Ta 
(mmAl) 
Tb 
(mmAl) 
Ka 
(mGy) 
Kb 
(mGy) 
HVL 
(mmAl) 
26 5.19 0.4 0.3 2.43 2.87 0.36 
28 6.67 0.4 0.3 3.19 3.79 0.37 
32 9.91 0.5 0.4 4.39 5.03 0.41 
Table  4.2: The HVL of 26, 28, 32 kVp for Mo/Rh target/filter mammography x-ray tube 
The measurements of the HVLs in Tables 4.1 and 4.2 show the relationship between 
the increase of the x-ray tube voltage kVp, and the HVL for both Mo/Mo and Mo/Rh 
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target/filter combinations. Figure 4.1 shows this relationship graphically. An increase 
in kVp requires more aluminum to be used to obtain the first HVL. The estimated 
uncertainty in this figure is 3%.  
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Figure  4.1: The relationship between the x-ray tube voltage (kVp) and the beam quality (HVL) for Mo/Mo 
and Mo/Rh target/filter mammography x-ray tube 
The HVL values at each kVp can be used to determine the MGD. MGD is the mean 
dose received by the glandular tissue in the whole breast and is an approximation of 
the actual patient dose [7, 16, 60]. Therefore, MGD is a quantity determine by 
standard tables with the knowledge of the entrance surface exposure, HVL, 
target/filter used, breast thickness and composition.  
4.1.1 Interpolate the Normalized Glandular Dose  
These standard tables are available at Wu X et al [21-22] include the normalized 
glandular dose values DgN as a function of beam quality, but do not cover the kVp and 
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the breast thickness 7.5cm used in this research  directly. A linear interpolation was 
used for the relationship between the HVL and the DgN to find the DgN at a nominal 
corresponding to our phantom thickness and beam parameters. To obtain the 
correspond DgN for the first kVp in this research 26kVp we must drew the DgN for 
25kVp and 27kVp at different HVL for a phantom thickness 7cm from the literature 
[21] and then find the average of the DgN at each HVL related to 26kVp, see Figure 
4.2. 
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Figure  4.2 : Linear relationship between the HVL and the normalized glandular dose at 25 and 27 kVp with 
by Mo/Mo target/filter for 7cm breast phantom thickness. 
By repeating the same method of the interpolation but for a phantom with 8cm 
thickness at different HVL for 25kVp and 27kVp, and then finding the average for the 
DgN for these two kVps we will get the DgN for 26 kVp at these HVL for a phantom 
with 8cm thickness. Finding the average of the DgN at each HVL for the 7cm and 8cm 
phantom thickness will end with the DgN for our phantom 7.5cm at different HVL for 
26kVp.  
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For the other kVp values covered in this research the same interpolation method was 
applied. 
 
 Table 4.3 shows these values (interpolated from the literature) at the energies used 
and HVL measured in this research, and also other thicknesses related to the depths 
used in this research with more concern with 7.5cm. 
Table  4.3: Normalized glandular dose (DgN) for Mo/Mo and 50% glandular- 50% adipose breast     
glandular tissue dose (mrad) for surface exposure of 1R at different breast thicknesses. 
The reason for using old units’ “milliards (mrad)” and “Rontgen (R)” is because 
standard tables use these units. This is why they were used in this research. Table 4.3 
is adapted from Wu X et al [21].  
Compressed breast thickness (cm) 
X-ray 
Tube 
voltage, 
HVL 
(mmAl) 
3 3.3 4 4.3 5 5.3 6 7 7.5 8 
26 kVp  
0.29 203 189 156 146 124 118 103 82 79 75 
0.31 215 200 165 155 132 125 109 92 86 80 
0.35 238 222 183 172 147 139 121 103 96 89 
28 kVp  
0.29 205 191 158 149 127 120 105 89 83 77 
0.31 218 203 168 158 134 127 111 94 88 82 
0.35 241 225 186 175 149 141 123 105 98 91 
32 kVp  
0.31 222 207 172 162 139 132 115 98 92 85 
0.35 244 228 190 179 153 145 127 108 101 94 
 36 
The values from Table 4.3, were used to study the relationship between the 
normalized glandular dose DgN and different breast phantom thicknesses i.e. 
comparing 7.5cm to other thicknesses, for different beam qualities. This relationship 
is shown in Figures 4.3, 4.4 and 4.5. The uncertainties in the values (polynomial line) 
were estimated to be within 3%. 
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Figure  4.3 : Normalized glandular dose (mrad/R) at 26 kVp for Mo/Mo x-ray tube plotted as a function of 
depth for three different HVLs (mmAl) 
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Figure  4.4 : Normalized glandular dose (mrad/R) at 28 kVp for Mo/Mo x-ray tube plotted as a function 
of depth for three different HVLs (mmAl) 
75
95
115
135
155
175
195
215
235
2
2.
5 3
3.
5 4
4.
5 5
5.
5 6
6.
5 7
7.
5 8
8.
5
Thickness (cm)
N
o
rm
a
liz
e
d 
Gl
a
n
du
la
r 
D
o
se
(m
ra
d/
R
)
HVL=0.31mmAl
HVL=0.35mmAl
Poly. (HVL=0.35mmAl)
Poly. (HVL=0.31mmAl)
 
Figure  4.5 : Normalized glandular dose (mrad/R) at 32 kVp for Mo/Mo x-ray tube plotted as a function 
of depth for two different HVLs (mmAl) 
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Figure 4.5 shows only 32kVp with Mo/Mo target/filter. That was because no data was 
available in the literature, relating to the increase on the kVp which requires having 
more aluminum layers. This leads to an increase in the first HVL value. 
 
The next step was to find the relationship between the normalized glandular dose for a 
7.5cm phantom thickness for the Mo/Rh target/filter combination. This required using 
the standard tables for this target/filter [22]. Table 4.4 shows these values at the 
energies and different thickness which were done in the same way for Mo/Mo. 
Compressed breast thickness (cm) 
X-ray 
Tube 
voltage, 
HVL 
(mmAl) 
3 3.3 4 4.3 5 5.3 6 7 7.5 8 
26 kVp  
0.36 249 233 194 183 156 148 130 110 103 96 
0.37 254 237 198 187 160 152 133 113 106 98 
0.41 277 259 216 204 175 166 145 124 116 107 
28 kVp  
0.36 251 235 196 185 158 150 131 112 105 97 
0.37 256 239 199 188 162 154 135 115 108 100 
0.41 278 260 218 206 177 168 147 125 117 109 
32 kVp  
0.41 280 262 220 208 179 170 149 127 119 110 
Table  4.4 : Normalized glandular dose (DgN) for Mo/Rh and 50% glandular- 50% adipose breast glandular 
tissue dose (mrad) for 1R at different breast thicknesses. 
Table 4.4 is adapted from the standard tables for the Mo/Rh target/filter by Wu et al 
[22].  
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Figures 4.6, 4.7 and 4.8, show the relationship between the normalized glandular dose 
and different phantom breast thicknesses with an uncertainty of 3%, as a function of 
kVp for the beam qualities measured in this research for Mo/Rh target/filter 
combination.  
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Figure  4.6 : Normalized glandular dose (mrad/R) at 26 kVp for Mo/Rh x-ray tube plotted as a function of 
depth for three different HVLs (mmAl) 
 
 40 
80
110
140
170
200
230
260
2
2.
5 3
3.
5 4
4.
5 5
5.
5 6
6.
5 7
7.
5 8
8.
5
Thickness (cm)
No
rm
al
iz
ed
 
G
la
n
du
la
r 
Do
se
(m
ra
d/
R)
HVL=0.36mmAl
HVL=0.37mmAl
HVL=0.41mmAl
Poly. (HVL=0.41mmAl)
Poly. (HVL=0.37mmAl)
Poly. (HVL=0.36mmAl)
 
Figure  4.7 : Normalized glandular dose (mrad/R) at 28 kVp for Mo/Rh x-ray tube plotted as a function of 
depth for three different HVLs (mmAl) 
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Figure  4.8 : Normalized glandular dose (mrad/R) at 32 kVp for Mo/Rh x-ray tube plotted as a function of 
depth for HVLs = 0.41 (mmAl) 
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The reason for having only one HVL=0.41mmAl in Figure 4.8 is because there were 
no data available in the literature. 
 
4.1.2  Mean Glandular Dose 
Finding the mean glandular dose, MGD, is the next step after interpolated DgN. In this 
research our concern was a phantom with 7.5cm thickness. The DgN values were 
inserted into equation 1 to find the mean glandular dose (MGD) for the 7.5cm 
thickness. This was done after measuring the entrance surface exposure (XESE) for 
each energy from both the Mo/Mo and the Mo/Rh target/filter combinations .  
 
Using the DgN values from Table 4.3 and inserting them into equation 1 produces 
Table 4.5 which has the MGD for the phantom thickness of 7.5cm for the x-ray 
energies used at different HVLs, for the Mo/Mo target/filter. In addition, to make sure 
that the entrance surface exposure is same for each kVp at different HVL, this study 
adjust the mAs for each kVp. 
Table  4.5 : Mean glandular dose (MGD) at the phantom surface (thickness = 7.5 cm) for Mo/Mo 
target/filter x-ray tube for 26, 28, and 32 kVp 
MGD (mGy) X-ray tube 
voltage, 
(kVp) 
XESE 
(R) 
Thickness 
(cm) HVL=0.29 
(mmAl) 
HVL=0.31 
(mmAl) 
HVL=0.35 
(mmAl) 
26 1.98 7.5 1.56 1.70 1.89 
28 1.28 7.5 1.06 1.12 1.25 
32 1.19 7.5 == 1.09 1.20 
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 The unit used for the entrance surface exposure is “Roentgen” in Table 4.5, this was 
converted to SI units to find the MGD for each kVp in equation 1, which is designed 
to use Roentgen for XESE. Using Table 4.5 to study the changes in the MGD with the 
change of the beam quality for the same target/filter (Mo/Mo), can be plotted in 
Figure 4.9. 
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Figure  4.9 : The effect of the beam quality (HVL) on the mean glandular dose (MGD) for Mo/Mo 
target/filter. 
Table 4.6 shows the MGD for the same phantom produced by using the DgN of Mo/Rh 
target/filter combination in Table 4.4 after measuring the entrance surface dose and 
inserting both of the values in equation 1.   
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MGD (mGy) X-ray tube 
voltage, 
(kVp) 
XESE 
(R) 
Thickness 
(cm) HVL=0.36 
(mmAl) 
HVL=0.37 
(mmAl) 
HVL=0.41 
(mmAl) 
26 1.39 7.5 1.43 1.47 1.61 
28 1.15 7.5 1.20 1.24 1.34 
32 1.09 7.5 == == 1.29 
Table  4.6: Mean glandular dose (MGD) at the phantom surface (thickness = 7.5 cm) for Mo/Rh target/filter 
x-ray tube for 26, 28, and 32 kVp 
Figure 4.10 shows the resulting relationship between kVp and MGD for one beam 
quality. Due to the time limitations more HVLs would have been covered.  
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Figure  4.10 : The effect of the beam quality (HVL) on the mean glandular dose (MGD) for Mo/Rh 
target/filter. 
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4.2 Measuring the Dose as a function of Depth 
 
TLDs were used to detect the dose at different depths inside the phantom, 
starting from the phantom surface to other depths of 3.3, 4.3 and 5.3cm. 
  
After following the process of reading out all the TLDs measurements, this research 
compared the TLDs reading at each depth for each kVp, with the ionization chamber 
under the same conditions. The same process was followed for both target/filter 
combinations used in this research (Mo/Mo and Mo/Rh). Because the number of the 
TLDs was used at each depth (8 to 15) the average reading of the TLDs at each depth 
was used as the best value. Typically, TLDs give readings with a standard deviation 
around the mean of 3% [46], so an average reading is desirable. In other words, all the 
TLD readings with high standard deviations were excluded from the average 
calculations.     
 
The TLDs readings at different kVps, surface and depths for the two target/filters 
used, can be found in Appendix A. One representative table is shown in Table 4.7 
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Depth = Surface, 26 kVp, 140 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
 
193.484 186.246 189.865 17.260 0.091 17.26 ± 0% 
238.444 228.491 233.468 17.260 0.074 17.23 ± 3.0% 
241.935 237.193 239.564 17.260 0.072 17. 24 ± 2.0% 
247.682 240.346 244.014 17.260 0.071 17. 23 ± 3.0% 
223.956 219.472 221.714 17.260 0.078 17.24 ± 2.0% 
203.279 197.461 200.370 17.260 0.086 17.23 ± 3.0% 
246.899 239.472 243.186 17.260 0.071 17.24 ± 2.0% 
250.004 247.613 248.809 17.260 0.069 17.23 ± 3.0% 
246.299 240.954 243.627 17.260 0.071 17. 24 ± 2.0% 
238.528 231.746 235.137 17.260 0.073 17. 23 ± 3.0% 
274.554 269.912 272.233 17.260 0.063 17. 24 ± 2.0% 
263.56 259.461 261.511 17.260 0.066 17. 24 ± 2.0% 
216.014 211.032 213.523 17.260 0.081 17. 23 ± 3.0% 
251.772 249.347 250.560 17.260 0.069 17. 23 ± 3.0% 
Table  4.7 : The TLDs reading at the phantom surface, using Mo/Mo, and 26 kVp 
The last two columns in Table 4.7 need to be clarified. The calibration factor (CF) is a 
quantity that represents the amount of dose delivered to the detectors (TLDs) by 
(mGy) divided by the average of the detectors readings (nC) [46]. 
 
where the TLD dose represents the dose delivered to the TLDs after conversion into 
(mGy). This can be done by multiplying the calibration factor for each measurement 
with the average reading for each TLD [46]. 
TLDeachforreadingAverageFactornCalibratioDoseTLD ×=
 
 
)(
)(
nCreadingdosimeteraverage
mGydosimetersthetodelivereddoseFactornCalibratio =
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The TLD dose average was used to represent the reading at kVp for each target/filter 
combination as a function of depth, with an uncertainty of 3%.  
 
One of the goals in this research was to study the relationship between the changes in 
dose as a function of depth. Figures 4.11 and 4.12 show this relationship for each kVp 
for the two target/filter combinations used respectively.  
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Figure  4.11 : The average TLD dose for Mo/Mo target/filter at 26, 28, and 32 kVp as a function of depth. 
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Figure  4.12 : The average TLD dose for Mo/Rh target/filter at 26, 28, and 32 kVp as a function of depth. 
From the Tables 4.7 and 4.8-4.12 Appendix A, we can study the relation between the 
surface dose 7.5cm, as a function of the kVp for both target/filter combinations. 
Figure 4.13 shows this change as a comparison for the combinations target/filter used 
in this research. 
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Figure  4.13 : The change on the surface dose for both Mo/Mo and Mo/Rh target/filter as a function of kVp. 
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5 Discussion and Conclusion 
Figure 5.1 compares the results from this research (a) with the results from Wu X 
et al [22] (b). It shows the relationship between the x-ray tube voltage (kVp) and the 
beam quality (HVL) for a Mo target/ 0.03mm Mo filter and a Mo target/ 0.25mm Rh 
as a function of kVp. Note, this work’s results values, include the attenuation of the 
compression paddle. This figure also shows what the HVL value depends on. The 
HVL value increases as kVp increases and the values for the Mo/Rh are higher than 
the Mo/Mo. This means the HVL depends on the atomic number of the target/filter 
used. The values from this research match well with the values from Wu X et al [22] 
in the Mo/Rh target/filter. It can be noted that the values work within the uncertainty 
for both. In the part of the Mo/Mo target/filter combination however, there is a 
difference with the measurements. 
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Figure  5.1 : The half value layer versus kVp for a Mo target/Mo filter and Mo target/Rh filter plotted as a 
function of kVp. 
In this research, after measuring the HVL for the target/filter combinations used- 
Mo/Mo and Mo/Rh- the data presented in Tables 4.3 and 4.4 respectively, show the 
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values for the DgN for different thicknesses. Combining these DgN values for both 
filters, at each kVp, and plotting them as a function of depth to compare the change as 
the filters change, see Figures 5.2, 5.3 and 5.4. 
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Figure  5.2 : Normalized glandular dose at 26 kVp, plotted as a function of 50/50 phantom for Mo/Mo and 
Mo/Rh target/filter x-ray tube 
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Figure  5.3 : Normalized glandular dose at 28 kVp, plotted as a function of 50/50 phantom for Mo/Mo and 
Mo/Rh target/filter x-ray tube. 
 50 
60
80
100
120
140
160
180
200
220
240
260
280
2
2.
5 3
3.
5 4
4.
5 5
5.
5 6
6.
5 7
7.
5 8
Thickness (cm)
No
rm
al
iz
ed
 
gl
an
du
la
r 
do
se
 
(m
ra
d/
R)
HVL=0.31mmAl Mo/Mo
HVL=0.35mmAl Mo/Mo
HVL=0.41mmAl Mo/Rh
Poly. (HVL=0.41mmAl Mo/Rh)
Poly. (HVL=0.35mmAl Mo/Mo)
Poly. (HVL=0.31mmAl Mo/Mo)
 
Figure  5.4 : Normalized glandular dose at 32 kVp, plotted as a function of 50/50 phantom for Mo/Mo and 
Mo/Rh target/filter x-ray tube. 
As illustrated in Figures 5.2, 5.3 and 5.4, the normalized glandular dose increases as 
the HVL increases at the same depth, for the same target/filter combination. The DgN 
values for the Mo/Rh are greater than the DgN values using the Mo/Mo. This is 
considered a result of the spectra differences between the target/filter used. In other 
words, the Mo/Rh requires less entrance exposure dose XESE to achieve better image 
quality, without exposing the breast to a high surface exposure dose. It can also be 
seen from these figures that, as the thickness of the phantom increases, the normalized 
glandular dose decreases.  
If we try to compare the results from this work with other researches, under the 
relationship between the phantom (breast) thickness and the normalized glandular 
dose, for one of the target/filter combinations (Mo/Mo) we will get this Figure 5.5. 
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Figure  5.5 : Normalized glandular dose plotted as a function of 50/50 phantom for Mo/Mo target/filter 
x-ray tube. The curve in blue is from this work and the curve in red from Sobol et al work [58]. 
 
The results in Figure 5.5 show a good matching between this work and Sobol et al 
[58] work taking into consideration the difference of kVp and the HVL used.  
Combining Figures 4.9 and 4.10 for the Mo/Mo and Mo/Rh target/filter respectively, 
to see the change on the MGD values as a function of the kVp, applied by different 
target/filter combinations at the phantom surface, can be seen in Figure 5.6. 
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Figure  5.6 : Comparing the change on the MGD for a 7.5cm phantom thickness with the change of kVp for 
different HVLs at different target/filter combinations. 
Looking at Figure 5.6, it can be seen that as the kVp increases at both target/filters, 
the DgN decreases and as previously mentioned, the kVp increases the XESE decreases 
for both target/filter as well. Figure 5.6 shows the expectation from the Tables 4.5 and 
4.6 that when the kVp increases, the MGD decreases resulting in the change in MGD 
values with Mo/Rh target/filter combination to be less steep than the change with 
Mo/Mo target/filter combination.  
In addition the MGD values with the Mo/Rh target/filter are higher than the Mo/Mo, 
especially for higher kVp. 
  
Figure 5.7 shows the Figures 4.11 and 4.12, where both show that as the depth 
increases, the dose decreases due to the increase of the attenuation of the x-ray beam 
inside the phantom.  
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(a)                                                                     (b) 
Figure  5.7 : (a) Figure 4.11, (b) Figure 4.12. 
Figures a and b show the average TLD dose at a specific depth dependence on the 
kVp used for the target/filter, where, as the kVp increases this value will decrease for 
the same depth.  
In addition, we compared the relationship between the average TLDs dose as a 
function of depth for the Mo/Mo with the Mo/Rh target/filter. In Figures 4.11 and 
4.12 it can be seen that the Mo/Rh values are higher than the Mo/Mo values at the 
same depth, for the same kVp value. This is due to the spectrum differences between 
the Mo/Mo and the Mo/Rh target/filter used. As mentioned before the Mo/Rh 
spectrum is higher than that of the Mo/Mo.   
 
This research measured the dose at the surface of the phantom (breast). Figure 4.13 
shows, the average of the TLD dose changes as a function of kVp. It is expected that 
the Mo/Mo target/filter has a higher entrance exposure dose XESE to achieve the better 
image quality. In other words it exposes the patient to less surface dose. Figure 4.13 
shows that as the kVp value increases, the surface dose will decrease. This takes into 
consideration the spectral differences between the Mo/Mo and the Mo/Rh target/filter 
combinations, where the Mo/Rh target/filter has less entrance exposure dose than the 
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Mo/Mo target/filter at the same kVp. This shows the advantage of the Mo/Rh over the 
Mo/Mo target/filter, in terms of dose saving. Therefore, as the phantom thickness 
increases the penetrating ability of the Mo/Rh is higher than that of the Mo/Mo. The 
entrance exposure dose required is less than the Mo/Rh, therefore it is more dose 
saving. The penalty of having this advantage is in the image contrast. With the 
Mo/Rh, the image contrast is poor compared to the image produced using the Mo/Mo.     
 
From the above, the dose expresses the energy deposited or absorbed in a specific 
tissue. In the breast, the glandular tissue is the radiosensitive tissue. Generally, the 
mean glandular dose is known as the reasonable quantity to represent the dose within 
the breast in regard to the risk of the ionizing radiation [61-63].  
 
Measuring the MGD directly is not possible [7, 16]; therefore it requires measuring 
the entrance surface exposure and taking into consideration the breast thickness and 
composition [16, 21-22]. Because of that different models were created to understand 
the homogeneity of the breast tissue mixture. In other words, the glandular tissue 
composition inside the breast depends on different factors: the breast thickness and 
age [20, 64]. One of these models is the 50 glandular/50 fat tissues. This is considered 
to be the most appropriate model to represent the standard breast [16, 20]. However, 
this model is not an appropriate presentation of breasts with more than 6cm or less 
than 4cm thickness (less or more glandular tissue respectively). Age is not considered 
in this model [4, 25]. 
 
Therefore, measuring the dose delivered to the breast, as a function of depth, will give 
a better understanding for the mammography dose [16]. In this research, studying the 
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dose as a function of depth, did not take into consideration the different glandular 
tissue compositions within the breast, the age of the woman and the breast thickness. 
In addition, understanding the change of the dose inside the breast, will help to decide 
the upper limit for the surface dose in mammography which has not been confirmed 
by the International Atomic Energy Agency (IAEA) [4].  
 
In conclusion, the mean glandular dose is the most common quantity used to represent 
the risk from the ionizing radiation used in the mammography screening, because of 
the sensitivity of the mammary glands. Measuring the MGD directly is not 
achievable, due to the need to measure the entrance surface exposure, taking into 
consideration the different factors which affect the MGD value-for example the kVp, 
target/filter combination, breast thickness and the beam quality (HVL).  
 
The breast phantom models are designed to measure the MGD on the assumption that 
the breast mixture tissues, in a homogenous situation, without considering the effect 
of age and the thickness of the breast on the glandular tissue distribution within the 
breast. 
IAEA states that MGD should be between (3-5) mGy for the average breast thickness. 
Women with a breast thickness smaller than the average breast thickness will receive 
a lower MGD, and those with a bigger breast thickness will receive higher a MGD 
[25]. 
 
On the other hand, measuring the change of the dose, as a function of depth, will 
provide a better understanding of the change of the dose inside the breast depending 
on the kVp, target/filter combination, beam quality and the entrance surface exposure. 
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Also, observing the change of the dose as a function of depth, can provide better 
calculation of the surface dose of mammography and therefore, reduce the risk of 
cancer from the mammography. 
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Appendix A 
Tables 
Depth = Surface, 28 kVp,  71mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
132.087 130.792 131.440 11.230 0.085 11.230 ±  0% 
120.643 115.972 118.308 11.230 0.095 11.210 ± 2.0% 
158.889 152.647 155.768 11.230 0.072 11.198 ± 3.2%  
123.85 120.091 121.971 11.230 0.092 11.216 ± 1.4% 
165.118 170.41 167.764 11.230 0.067 11.210 ± 2.0% 
182.34 176.494 179.417 11.230 0.063 11.209 ± 2.1% 
172.884 168.002 170.443 11.230 0.066 11.210 ± 2.0% 
161.029 158.135 159.582 11.230 0.070 11.200 ± 3.0% 
147.623 142.764 145.194 11.230 0.077 11.206 ± 2.4% 
160.429 152.138 156.284 11.230 0.072 11.215 ± 1.5% 
180.17 176.843 178.507 11.230 0.063 11.209 ± 2.1% 
177.64 174.084 175.862 11.230 0.064 11.213 ± 1.7% 
Table 4.8: The TLDs reading at the phantom surface, using Mo/Mo, and 28 kVp. 
 
Depth = Surface, 32 kVp, 45 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
143.582 139.462 141.522 10.410 0.074 10.410 ± 0% 
155.813 148.327 152.070 10.410 0.068 10.373 ± 3.7% 
156.16 161.012 158.586 10.410 0.066 10.369 ± 3.3% 
145.278 139.487 142.383 10.410 0.073 10.384 ± 2.6% 
143.94 137.648 140.794 10.410 0.074 10.372 ± 3.8% 
166.009 157.913 161.961 10.410 0.064 10.369 ± 3.7% 
148.975 140.681 144.828 10.410 0.072 10.379 ± 3.1% 
165.917 158.698 162.308 10.410 0.064 10.386 ± 2.4% 
148.447 139.741 144.094 10.410 0.072 10.382 ± 2.8% 
174.11 167.852 170.981 10.410 0.061 10.378 ± 3.2% 
Table 4.9: The TLDs reading at the phantom surface, using Mo/Mo, and 32kVp 
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Depth = Surface, 26 kVp, 125 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
175.609 169.403 172.506 12.130 0.070 12.130 ± 0% 
186.789 180.579 183.684 12.130 0.066 12.102 ± 2.8% 
189.5 182.359 185.930 12.130 0.065 12.105 ± 2.5% 
169.139 164.487 166.813 12.130 0.073 12. 109 ± 2.1% 
187.847 179.587 183.717 12.130 0.066 12.107 ± 2.3% 
195.728 189.597 192.663 12.130 0.063 12.106 ± 2.4% 
199.098 191.987 195.543 12.130 0.062 12.108 ± 2.2% 
190.287 184.214 187.251 12.130 0.065 12.107 ± 2.3% 
216.263 209.247 212.755 12.130 0.057 12.108 ± 2.2% 
247.449 240.578 244.014 12.130 0.050 12.107 ± 2.3% 
 229.868 225.981 227.925 12.130 0.053 12.108 ± 2.2% 
243.879 239.167 241.523 12.130 0.050 12.104 ± 2.6% 
244.3 239.143 241.722 12.130 0.050 12.103 ± 2.7% 
Table 4.10: The TLDs reading at the phantom surface, using Mo/Rh, and 26 kVp. 
 
Depth = Surface, 28 kVp, 80 mAs 
Reading1 
(nC) 
 
Reading2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
186.288 180.642 183.465 10.050 0.055 10.050 ± 0% 
187.282 176.379 181.831 10.050 0.055 10.025 ± 2.5% 
173.65 163.147 168.399 10.050 0.060 10.028 ± 2.2% 
195.526 188.249 191.888 10.050 0.052 10.029 ± 2.1% 
166.557 162.497 164.527 10.050 0.061 10.021 ± 2.9% 
180.211 174.915 177.563 10.050 0.057 10.025 ± 2.5% 
217.778 208.317 213.048 10.050 0.047 10.028 ± 2.2% 
181.072 177.246 179.159 10.050 0.056 10.026 ± 2.4% 
164.026 160.327 162.177 10.050 0.062 10.027 ± 2.3% 
205.214 197.468 201.341 10.050 0.050 10.029 ± 2.1% 
199.658 193.168 196.413 10.050 0.051 10.023 ± 2.7% 
200.199 196.348 198.274 10.050 0.051 10.026 ± 2.4% 
202.822 194.138 198.480 10.050 0.051 10.020 ± 3.0% 
192.947 187.345 190.146 10.050 0.053 10.027 ± 2.3% 
Table 4.11: The TLDs reading at the phantom surface, using Mo/Rh, and 28 kVp. 
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Depth = Surface, 32 kVp, 50 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
162.003 156.247 159.125 9.590 0.060 9.590 ± 0% 
169.384 155.981 162.683 9.590 0.059 9.560 ± 3.0% 
 182.479 173.157 177.818 9.590 0.054 9.562 ± 2.8% 
191.564 185.264 188.414 9.590 0.051 9.569 ± 2.1% 
148.181 155.971 152.076 9.590 0.063 9.563 ± 2.7% 
198.804 191.341 195.073 9.590 0.049 9.563 ± 2.7% 
188.826 180.642 184.734 9.590 0.052 9.561 ± 2.9% 
196.86 188.264 192.562 9.590 0.050 9.562 ± 2.8% 
201.99 197.346 199.668 9.590 0.048 9.563 ± 2.7% 
169.164 172.648 170.906 9.590 0.056 9.562 ± 2.8% 
200.104 195.317 197.711 9.590 0.049 9.568 ± 2.2% 
Table 4.12: The TLDs reading at the phantom surface, using Mo/Rh, and 32 kVp. 
Table 4.13: The TLDs reading at 5.3 cm depth from the surface, using Mo/Mo, and 26 kVp. 
 
 
 
 
 
 
 
Depth = 5.3 cm, 26 kVp, 140 mAs 
Reading1 
(nC) 
 
Reading2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
5.932 5.456 5.694 0.286 0.050 0.255 ± 3.1% 
6.081 5.724 5.903 0.286 0.048 0.256 ± 3.0% 
6.033 5.924 5.979 0.286 0.048 0.256 ± 3.0% 
6.424 5.871 6.148 0.286 0.047 0.253 ± 3.3% 
6.957 6.135 6.546 0.286 0.044 0.255 ± 3.1% 
7.053 6.419 6.736 0.286 0.042 0.257 ± 2.9% 
6.669 5.843 6.256 0.286 0.046 0.252 ± 3.4% 
5.572 5.134 5.353 0.286 0.053 0.259 ± 2.7% 
6.304 5.854 6.079 0.286 0.047 0.252 ± 3.4%  
6.034 5.16 5.597 0.286 0.051 0.258 ± 2.8% 
5.314 5.987 5.651 0.286 0.051 0.257 ± 2.9% 
6.06 6.197 6.129 0.286 0.047 0.258 ± 2.8% 
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Depth = 4.3 cm, 26 kVp, 140 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
11.579 11.235 11.407 0.583 0.051 0.583 ± 0% 
11.556 10.891 11.224 0.583 0.052 0.553 ± 3.0% 
13.735 12.672 13.204 0.583 0.044 0.553 ± 3.0% 
11.896 10.924 11.410 0.583 0.051 0.555 ± 2.8% 
10.744 10.397 10.571 0.583 0.055 0.556 ± 2.7% 
14.084 14.571 14.328 0.583 0.041 0.557 ± 2.6% 
13.213 12.843 13.028 0.583 0.045 0.559 ± 2.4% 
13.078 12.137 12.608 0.583 0.046 0.555 ± 2.8% 
13.141 12.896 13.019 0.583 0.045 0.559 ± 2.4% 
12.856 12.597 12.727 0.583 0.046 0.554 ± 2.9% 
12.898 12.972 12.935 0.583 0.045 0.556 ± 2.7% 
13.342 12.951 13.147 0.583 0.044 0.555 ± 2.8% 
Table 4.14: The TLDs reading at 4.3 cm depth from the surface, using Mo/Mo, and 26 kVp. 
 
Depth = 3.3 cm, 26 kVp, 140 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
21.248 20.954 21.101 1.205 0.057 1.205 ± 0% 
22.067 21.851 21.959 1.205 0.055 0.946 ± 2.6% 
21.777 21.53 21.654 1.205 0.056 0.948 ± 2.6% 
22.53 21.813 22.172 1.205 0.054 0.947 ± 2.6% 
21.357 21.871 21.614 1.205 0.056 0.949 ± 2.6% 
23.984 22.649 23.317 1.205 0.052 0.948 ± 2.6% 
23.22 22.75 22.985 1.205 0.052 0.949 ± 2.6% 
25.711 24.573 25.142 1.205 0.048 0.946 ± 2.7% 
22.54 21.651 22.096 1.205 0.055 0.949 ± 2.7% 
24.855 23.648 24.252 1.205 0.050 0.948 ± 2.6% 
22.772 21.91 22.341 1.205 0.054 0.945 ± 2.6% 
23.781 22.813 23.297 1.205 0.052 0.947 ± 2.6% 
23.432 23.871 23.652 1.205 0.051 0.948 ± 2.7% 
24.355 23.841 24.098 1.205 0.050 0.949 ± 2.6% 
23.563 22.823 23.193 1.205 0.052 0.947 ± 2.6% 
Table 4.15: The TLDs reading at 3.3 cm depth from the surface, using Mo/Mo, and 26 kVp. 
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Depth = 5.3 cm, 28 kVp, 71mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
5.172 5.133 5.153 0.218 0.042 0.218 ± 0% 
5.101 5.13 5.116 0.218 0.043 0.180 ± 3.8% 
5.177 5.049 5.113 0.218 0.043 0.181 ± 3.7% 
5.005 5.039 5.022 0.218 0.043 0.189 ± 2.9% 
5.227 5.066 5.147 0.218 0.042 0.182 ± 3.6% 
5.568 5.351 5.460 0.218 0.040 0.189 ± 2.9% 
5.709 5.56 5.635 0.218 0.039 0.182 ± 3.6% 
5.349 5.305 5.327 0.218 0.041 0.181 ± 3.7% 
5.539 5.651 5.595 0.218 0.039 0.183 ± 3.5% 
5.521 5.769 5.645 0.218 0.039 0.189 ± 2.9% 
6.149 6.001 6.075 0.218 0.036 0.181 ± 3.7% 
5.709 5.827 5.768 0.218 0.038 0.182 ± 3.6% 
Table 4.16: The TLDs reading at 5.3 cm depth from the surface, using Mo/Mo, and 28 kVp. 
 
Depth = 4.3 cm, 28 kVp,  71 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
8.293 8.082 8.188 0.429 0.052 0.429 ± 0% 
8.602 8.182 8.392 0.429 0.051 0.399 ± 3.0% 
9.904 9.515 9.710 0.429 0.044 0.396 ± 3.3% 
8.578 8.143 8.361 0.429 0.051 0.397 ± 3.2% 
7.945 7.519 7.732 0.429 0.055 0.397 ± 3.2% 
10.111 9.736 9.924 0.429 0.043 0.396 ± 3.3% 
9.405 9.544 9.475 0.429 0.045 0.399 ± 3.0% 
9.193 9.313 9.253 0.429 0.046 0.397 ± 3.2% 
9.399 9.363 9.381 0.429 0.046 0.395 ± 3.4% 
9.111 9.143 9.127 0.429 0.047 0.398 ± 3.1% 
9.133 9.14 9.137 0.429 0.047 0.395 ± 3.4% 
9.74 9.833 9.787 0.429 0.044 0.396 ± 3.3% 
10.013 9.97 9.992 0.429 0.043 0.397 ± 3.2% 
10.073 10.103 10.088 0.429 0.043 0.399 ± 3.0% 
8.5 8.551 8.526 0.429 0.050 0.397 ± 3.2% 
Table 4.17: The TLDs reading at 4.3 cm depth from the surface, using Mo/Mo, and 28 kVp. 
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Depth = 3.3 cm, 28 kVp, 71 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
16.884 17.915 17.400 0.870 0.050 0.870 ± 0% 
17.084 18.214 17.649 0.870 0.049 0.844 ± 2.6% 
17.383 18.606 17.995 0.870 0.048 0.841 ± 2.9% 
17.655 19.036 18.346 0.870 0.047 0.845 ± 2.5% 
17.226 18.183 17.705 0.870 0.049 0.843 ± 2.7% 
19.062 20.417 19.740 0.870 0.044 0.842 ± 2.8% 
19.5 20.716 20.108 0.870 0.043 0.844 ± 2.6% 
20.395 21.505 20.950 0.870 0.042 0.841 ± 2.9% 
Table 4.18: The TLDs reading at 3.3 cm depth from the surface, using Mo/Mo, and 28 kVp. 
 
Depth = 5.3 cm, 32 kVp, 45 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
6.034 5.431 5.7325 0.263 0.046 0.263 ± 0% 
5.998 5.71 5.854 0.263 0.045 0.228 ± 3.5% 
6.152 6.013 6.0825 0.263 0.043 0.225 ± 3.8% 
6.137 5.73 5.9335 0.263 0.044 0.227 ± 3.6% 
6.187 5.736 5.9615 0.263 0.044 0.225 ± 3.8% 
6.252 6.004 6.128 0.263 0.043 0.226 ± 3.7% 
6.665 6.279 6.472 0.263 0.041 0.223 ± 3.3% 
6.548 6.197 6.3725 0.263 0.041 0.227 ± 3.6% 
6.67 6.257 6.4635 0.263 0.041 0.224 ± 3.3% 
6.801 6.249 6.525 0.263 0.040 0.228 ± 3.2% 
7.403 6.73 7.0665 0.263 0.037 0.225 ± 3.4% 
6.791 6.328 6.5595 0.263 0.040 0.226 ± 3.1% 
6.254 5.653 5.9535 0.263 0.044 0.229 ± 3.4% 
6.674 6.235 6.4545 0.263 0.041 0.229 ± 3.4% 
6.467 5.794 6.1305 0.263 0.043 0.231 ± 3.2% 
Table 4.19: The TLDs reading at 5.3 cm depth from the surface, using Mo/Mo, and 32 kVp. 
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Depth = 4.3 cm, 32 kVp, 45 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
9.844 9.647 9.7455 0.496 0.051 0.496 ± 0% 
10.105 10.254 10.1795 0.496 0.049 0.465 ± 3.1% 
11.694 11.941 11.8175 0.496 0.042 0.462 ± 3.4% 
10.13 10.297 10.2135 0.496 0.049 0.463 ± 3.3% 
9.04 8.901 8.9705 0.496 0.055 0.462 ± 3.4% 
11.875 11.9 11.8875 0.496 0.042 0.463 ± 3.3% 
11.326 11.519 11.4225 0.496 0.043 0.463 ± 3.3% 
11.127 11.518 11.3225 0.496 0.044 0.461 ± 3.5% 
11.387 11.649 11.518 0.496 0.043 0.460 ± 3.6% 
10.814 11.124 10.969 0.496 0.045 0.463 ± 3.3% 
10.458 10.745 10.6015 0.496 0.047 0.464 ± 3.2% 
11.386 11.649 11.5175 0.496 0.043 0.462 ± 3.4% 
Table 4.20: The TLDs reading at 4.3 cm depth from the surface, using Mo/Mo, and 32 kVp. 
 
Depth = 3.3 cm, 32 kVp, 45 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
20.552 18.526 19.539 0.956 0.049 0.924 ± 3.2% 
21.007 18.563 19.785 0.956 0.048 0.927 ± 2.9% 
21.212 19.867 20.5395 0.956 0.047 0.926 ± 3.0% 
20.285 18.525 19.405 0.956 0.049 0.924 ± 3.2% 
22.25 20.354 21.302 0.956 0.045 0.925 ± 3.1% 
22.933 20.654 21.7935 0.956 0.044 0.929 ± 2.7% 
23.813 21.991 22.902 0.956 0.042 0.929 ± 2.7% 
21.92 20.051 20.9855 0.956 0.046 0.921 ± 3.5% 
22.239 20.746 21.4925 0.956 0.044 0.927 ± 2.9% 
21.903 19.233 20.568 0.956 0.046 0.928 ± 2.8% 
22.423 20.359 21.391 0.956 0.045 0.924 ± 3.2% 
22.327 19.976 21.1515 0.956 0.045 0.927 ± 2.9% 
22.827 20.117 21.472 0.956 0.045 0.925 ± 3.1% 
22.028 19.61 20.819 0.956 0.046 0.928 ± 2.8% 
19.88 17.372 18.626 0.956 0.051 0.926 ± 3.0% 
Table 4.21: The TLDs reading at 3.3 cm depth from the surface, using Mo/Mo, and 32 kVp. 
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Depth = 5.3 cm, 26 kVp, 125 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
6.484 6.18 6.332 0.310 0.049 0.302 ± 2.8% 
6.445 6.495 6.470 0.310 0.048 0.285 ± 2.5% 
6.301 6.063 6.182 0.310 0.050 0.283 ± 2.7% 
6.686 6.388 6.537 0.310 0.047 0.289 ± 2.1% 
5.989 5.746 5.868 0.310 0.053 0.282 ± 2.8% 
6.95 6.514 6.732 0.310 0.046 0.281 ± 2.9% 
6.77 6.547 6.659 0.310 0.047 0.282 ± 2.8% 
6.84 6.98 6.910 0.310 0.045 0.285 ± 2.5% 
7.06 7.213 7.137 0.310 0.043 0.284 ± 2.6% 
7.526 7.572 7.549 0.310 0.041 0.281 ± 2.9% 
7.129 7.138 7.134 0.310 0.043 0.284 ± 2.6% 
6.304 6.165 6.235 0.310 0.050 0.281 ± 2.9% 
Table 4.22: The TLDs reading at 5.3 cm depth from the surface, using Mo/Rh, and 26 kVp. 
 
Depth = 4.3 cm, 26 kVp, 125 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
11.457 11.467 11.462 0.592 0.052 0.572 ± 2.0% 
12.051 12.154 12.103 0.592 0.049 0.565 ± 2.7% 
14.216 14.191 14.204 0.592 0.042 0.568 ± 2.4% 
11.864 11.735 11.800 0.592 0.050 0.560 ± 3.2% 
10.777 10.612 10.695 0.592 0.055 0.567 ± 2.5% 
14.078 14.376 14.227 0.592 0.042 0.564 ± 2.8% 
13.456 13.452 13.454 0.592 0.044 0.562 ± 3.0% 
13.235 13.581 13.408 0.592 0.044 0.566 ± 2.6% 
13.547 13.956 13.752 0.592 0.043 0.566 ± 2.6% 
13.436 13.342 13.389 0.592 0.044 0.560 ± 3.2% 
12.774 13.065 12.920 0.592 0.046 0.561 ± 3.1% 
13.839 13.912 13.876 0.592 0.043 0.565 ± 2.7% 
14.426 14.926 14.676 0.592 0.040 0.562 ± 3.0% 
Table 4.23: The TLDs reading at 4.3 cm depth from the surface, using Mo/Rh, and 26 kVp. 
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Depth = 3.3 cm, 26 kVp, 125 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
21.787 20.812 21.300 1.144 0.054 1.144 ± 0% 
21.38 20.7 21.040 1.144 0.054 1.113 ± 3.1% 
21.739 20.606 21.173 1.144 0.054 1.112 ± 3.2% 
22.552 21.971 22.262 1.144 0.051 1.114 ± 3.0% 
20.913 19.918 20.416 1.144 0.056 1.115 ± 2.9% 
23.508 22.549 23.029 1.144 0.050 1.112 ± 3.2% 
23.366 22.138 22.752 1.144 0.050 1.111 ± 3.3% 
25.415 24.996 25.206 1.144 0.045 1.113 ± 3.1% 
22.317 21.385 21.851 1.144 0.052 1.112 ± 3.2% 
24.317 24.479 24.398 1.144 0.047 1.114 ± 3.0% 
21.853 21.382 21.618 1.144 0.053 1.115 ± 2.9% 
23.196 22.801 22.999 1.144 0.050 1.116 ± 2.8% 
22.982 22.908 22.945 1.144 0.050 1.112 ± 3.2% 
23.589 23.239 23.414 1.144 0.049 1.110 ± 3.4% 
Table 4.24: The TLDs reading at 3.3 cm depth from the surface, using Mo/Rh, and 26 kVp. 
 
Depth = 5.3 cm, 28 kVp, 80 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
5.832 5.665 5.749 0.286 0.050 0.257 ± 2.9% 
6.009 5.73 5.870 0.286 0.049 0.258 ± 2.8% 
5.892 5.732 5.812 0.286 0.049 0.259 ± 2.7% 
6.159 5.713 5.936 0.286 0.048 0.257 ± 2.9% 
5.219 5.245 5.232 0.286 0.055 0.257 ± 2.9% 
6.084 5.825 5.955 0.286 0.048 0.259 ± 2.7% 
5.839 5.843 5.841 0.286 0.049 0.258 ± 2.8% 
6.284 5.975 6.130 0.286 0.047 0.259 ± 2.7% 
6.263 5.911 6.087 0.286 0.047 0.259 ± 2.7% 
6.994 6.551 6.773 0.286 0.042 0.257 ± 2.9% 
6.709 6.436 6.573 0.286 0.044 0.258 ± 2.8% 
5.536 5.108 5.322 0.286 0.054 0.257 ± 2.9% 
6.31 6.012 6.161 0.286 0.046 0.259 ± 2.7% 
5.799 5.646 5.723 0.286 0.050 0.256 ± 3.0% 
Table 4.25: The TLDs reading at 5.3 cm depth from the surface, using Mo/Rh, and 28 kVp. 
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Depth = 4.3 cm, 28 kVp, 80 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
10.509 10.715 10.612 0.536 0.051 0.536 ± 0% 
10.51 10.952 10.731 0.536 0.050 0.508 ± 2.8% 
12.594 12.827 12.711 0.536 0.042 0.509 ± 2.7% 
10.903 10.672 10.788 0.536 0.050 0.501 ± 3.5% 
9.63 9.812 9.721 0.536 0.055 0.509 ± 2.7% 
12.655 12.951 12.803 0.536 0.042 0.506 ± 3.0% 
12.308 12.468 12.388 0.536 0.043 0.509 ± 2.7% 
11.982 12.641 12.312 0.536 0.044 0.502 ± 3.4% 
12.382 12.758 12.570 0.536 0.043 0.503 ± 3.3% 
12.167 12.206 12.187 0.536 0.044 0.501 ± 3.5% 
11.719 12.092 11.906 0.536 0.045 0.508 ± 2.8% 
12.695 12.541 12.618 0.536 0.042 0.501 ± 3.5% 
13.405 13.094 13.250 0.536 0.040 0.502 ± 3.4% 
Table 4.26: The TLDs reading at 4.3 cm depth from the surface, using Mo/Rh, and 28 kVp. 
 
Depth = 3.3 cm, 28 kVp, 80 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
17.987 18.528 18.258 1.033 0.057 1.033 ± 0% 
18.342 18.247 18.295 1.033 0.056 1.001 ± 3.2% 
17.925 18.661 18.293 1.033 0.056 1.004 ± 2.9% 
19.792 19.981 19.887 1.033 0.052 1.003 ± 3.0% 
17.654 17.719 17.687 1.033 0.058 1.006 ± 2.7% 
20.774 20.524 20.649 1.033 0.050 1.003 ± 3.0% 
19.783 19.503 19.643 1.033 0.053 1.009 ± 2.4% 
21.981 22.455 22.218 1.033 0.046 1.002 ± 3.1% 
18.561 19.041 18.801 1.033 0.055 1.003 ± 3.0% 
21.398 21.878 21.638 1.033 0.048 1.002 ± 3.1% 
18.506 18.279 18.393 1.033 0.056 1.005 ± 2.8% 
20.118 20.128 20.123 1.033 0.051 1.007 ± 2.6% 
Table 4.27: The TLDs reading at 3.3 cm depth from the surface, using Mo/Rh, and 28 kVp. 
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Depth = 5.3 cm, 32kVp, 50 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
6.401 6.357 6.379 0.314 0.049 0.304 ± 1.0% 
6.443 6.243 6.343 0.314 0.050 0.285 ± 2.9% 
6.133 6.167 6.150 0.314 0.051 0.286 ± 2.8% 
6.385 6.065 6.225 0.314 0.050 0.283 ± 3.1% 
5.605 5.569 5.587 0.314 0.056 0.284 ± 3.0% 
6.644 6.532 6.588 0.314 0.048 0.283 ± 3.1% 
6.74 6.298 6.519 0.314 0.048 0.285 ± 2.9% 
6.682 6.554 6.618 0.314 0.047 0.284 ± 3.0% 
6.835 6.41 6.623 0.314 0.047 0.284 ± 3.0% 
7.226 7.215 7.221 0.314 0.043 0.283 ± 3.1% 
7.028 6.957 6.993 0.314 0.045 0.284 ± 3.0% 
5.668 5.719 5.694 0.314 0.055 0.286 ± 2.8% 
6.81 6.396 6.603 0.314 0.048 0.285 ± 2.9% 
6.024 5.816 5.920 0.314 0.053 0.284 ± 3.0% 
Table 4.28: The TLDs reading at 5.3 cm depth from the surface, using Mo/Rh, and 32 kVp 
 
Depth = 4.3 cm, 32kVp, 50 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
11.227 11.283 11.255 0.572 0.051 0.572 ± 0% 
11.927 12.18 12.054 0.572 0.047 0.544 ± 2.8% 
14.06 13.945 14.003 0.572 0.041 0.542 ± 3.0% 
11.722 12.012 11.867 0.572 0.048 0.546 ± 2.6% 
10.256 10.768 10.512 0.572 0.054 0.543 ± 2.9% 
13.781 14.231 14.006 0.572 0.041 0.543 ± 2.9% 
13.573 13.604 13.589 0.572 0.042 0.544 ± 2.8% 
13.554 13.739 13.647 0.572 0.042 0.542 ± 3.0% 
13.633 13.742 13.688 0.572 0.042 0.544 ± 2.8% 
12.697 13.238 12.968 0.572 0.044 0.546 ± 2.6% 
12.677 12.903 12.790 0.572 0.045 0.543 ± 2.9% 
13.517 13.698 13.608 0.572 0.042 0.549 ± 2.3% 
14.347 14.665 14.506 0.572 0.039 0.543 ± 2.9% 
Table 4.29: The TLDs reading at 4.3 cm depth from the surface, using Mo/Rh, and 32 kVp. 
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Depth = 3.3 cm, 32 kVp, 50 mAs 
Reading 1 
(nC) 
 
Reading 2 
(nC) 
 
Reading 
Average (nC) 
Ionization 
chamber dose 
(mGy) 
Calibration 
Factor 
(mGy/nC) 
TLD Dose 
(mGy) 
18.82 19.072 18.946 1.066 0.056 1.066 ± 0% 
19.114 19.045 19.080 1.066 0.056 1.038 ± 2.8% 
19.333 19.363 19.348 1.066 0.055 1.034 ± 3.2% 
20.469 20.225 20.347 1.066 0.052 1.038 ± 2.8% 
18.031 17.757 17.894 1.066 0.060 1.039 ± 2.7% 
20.603 20.423 20.513 1.066 0.052 1.036 ± 3.0% 
19.46 19.38 19.420 1.066 0.055 1.038 ± 2.8% 
22.719 22.851 22.785 1.066 0.047 1.031 ± 3.5% 
19.126 18.534 18.830 1.066 0.057 1.039 ± 2.7% 
22.271 21.661 21.966 1.066 0.049 1.036 ± 3.0% 
17.928 17.983 17.956 1.066 0.059 1.039 ± 2.7% 
20.382 19.667 20.025 1.066 0.053 1.032 ± 3.4% 
20.42 20.165 20.293 1.066 0.053 1.039 ± 2.7% 
21.352 21.136 21.244 1.066 0.050 1.032 ± 3.4% 
Table 4.30: The TLDs reading at 3.3 cm depth from the surface, using Mo/Rh, and 32 kVp. 
